Received: 25.12.2023/Accepted: 08.04.2024/Published online: 29.04.2024
УДК 616-053.2-248
DOI: 10.53511/pharmkaz.2024.17.61.018
D.ZH.SAUSSANOVA1, M.A.BAYMURATOVA1, A.S.TUGULBAEVA2, R.K.LOBANOV3, E.D.PAVLENKO4, A.D.ZHADIL5
1 Kazakh Medical University «Higher School of Public Health», Almaty, Kazakhstan
2 «Allergomed» Medical Center, Almaty, Kazakhstan
3 «Higher Medical College», Almaty, Kazakhstan
4 Perinatology and Pediatric Cardiac Surgery Center, Almaty, Kazakhstan
5 Research Institute of Cardiology and Internal Diseases, Almaty, Kazakhstan
CONTEMPORARY STATE OF DIAGNOSIS AND TREATMENT OF BRONCHIAL ASTHMA AMONG CHILDREN
Resume: This paper provides a brief overview of the current state of diagnosis and treatment of bronchial asthma among the
pediatric population, given the increasing incidence worldwide.
Materials and methods: Wiley, PubMed, Web of Science, Scopus databases and health compilations of the Republic of
Kazakhstan over a five-year period (2018-2023) were used for this review.
Currently, the WHO European Region is facing a significant threat from the growing incidence of preventable noncommunicable diseases (NCDs), among which chronic respiratory diseases are highlighted. These diseases not only reduce
the quality of life of individuals but also cause substantial economic damage to families, communities, and countries as a
whole, which underscores the relevance of our chosen topic. According to expert estimates, there are more than 350 million
people worldwide with bronchial asthma, with about 5-10% of cases being among the pediatric population. In Kazakhstan,
there is a steady trend of increasing incidence worldwide.
Keywords: Bronchial asthma, chronic non-communicable diseases, disease management program, GINA, modern treatment
methods, children.
REFERENCES
1 Global Burden of Disease Collaborative Network, Global Burden of Disease Study 2019 (GBD 2019) Results (2020,
Institute for Health Metrics and Evaluation – IHME) https://vizhub.healthdata.org/gbd-results/
2 UN. Sustainable Development Goals. Goal 3: Ensure healthy lives and promote well-being for all at all ages. – URL:
3 Prolonging Lives. Progress and achievements of the WHO European Office for the prevention of non-communicable
diseases and their control in 2017. – URL: http://miac.zdrav.spb.ru/docs/materialy-voz/2017- god/prodlevaya-zhizniprogress-i-dostizheniya-evropeiskogo-ofisa-voz-po-profilaktike-neinfekcionnyhzabolevanii-i-borbe-s-nimi-v-2017-g
4 Time to Deliver: Report of the WHO Independent High-level Commission on Noncommunicable Diseases [Time to deliver:
report of the WHO Independent High-level Commission on Noncommunicable Diseases]. Geneva: World Health Organization;
2018. – URL: https://apps.who.int/iris/ bitstream/handle/10665/272713/9789244514160-rus.pdf
5 Garmash V.Ya., Kulikov S.A. History of the development of ideas about bronchial asthma // Science of the Young – Eruditio
Juvenium. 2018. No. 2. URL: https://cyberleninka.ru/article/n/istoriya-razvitiya-predstavleniy-o-bronhialnoy-astme
6 Aringazina A.M., Yesimov N.B., Ismailova N.T. Disease management program in the Republic of Kazakhstan. Medicine
(Almaty). 2019. No. 1(199). Pp. 43-46.
7 Order of the Minister of Health of the Republic of Kazakhstan dated October 23, 2020 No. ҚР ДСМ-149/2020. Registered
in the Ministry of Justice of the Republic of Kazakhstan on October 26, 2020 No. 21513. «On approval of the rules for
organizing medical care for people with chronic diseases, frequency and terms of observation, the mandatory minimum and
frequency of diagnostic tests».
8 Amirov B.B., Kuanyshbekova R.T., Abdikaliev N.A., Madaliev K.N., Koshumbaeva K.M., Isabekova A.Kh., Asembekov B.S.,
Kabykenova R.K., Zharylkasynova R.K., Chernokurova E.A., Ibragimova F.S., Karaev R.Kh. Principles of introducing disease
management programs within the framework of dispensary services at the PHC level (literature review). Medicine (Almaty).
2019. No. 5 (203). Pp. 60-66.
9 Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention, 2023. Updated July 2023. Available
from: www.ginasthma.org.
10 Statistical Collection “Health of the Population of the Republic of Kazakhstan and Activities of Healthcare Organizations”
for the years 2013-2022.
11 Avdeev S.N., Nenasheva N.M., Zhudenkov K.V. et al. Prevalence, morbidity, phenotypes, and other characteristics of severe
bronchial asthma in the Russian Federation. Pulmonology. 2018; 28(3):341–358.
12 Asher M.I., Rutter C.E., Bissell K., et al. Worldwide trends in the burden of asthma symptoms in school-aged children:
Global Asthma Network Phase I cross-sectional study. Lancet 2021; 398: 1569-1580.
13 Mortimer K, Lesosky M, García-Marcos L, et al. The burden of asthma, hay fever and eczema in adults in 17 countries: GAN
Phase I study. Eur Respir J 2022.
14 Mathieu E., Ritchie H., Rodés-Guirao L., Appel C., Gavrilov D., Giattino C., Hasell J., Macdonald B., Dattani S., Beltekian D. et
al. Coronavirus Pandemic (COVID-19). Our World in Data. 2020.
15 Skevaki C., Karsonova A., Karaulov A., Fomina D., Xie M., Chinthrajah S., Nadeau K.C., Renz H. SARS-CoV-2 infection and
COVID-19 in asthmatics: A complex relationship. Nat. Rev. Immunol. 2021, 21, 202–203.
133
16 Nursoy M.A., Bülbül L., Yazıcı M., Altınel N., Kahraman F.U., Sağlam N.Ö., Duramaz B.B., Türel Ö., Çakır E. Comparison of
clinical features of COVID-19 infection in children with asthma and their healthy peers. Pediatr. Pulmonol. 2022, 57, 1693–
1700.
17 Yang Z., Wang X., Wan X., Wang M., Qiu Z., Chen J., Shi M., Zhang S., Xia Y. Pediatric asthma control during the COVID-19
pandemic: A systematic review and meta-analysis. Pediatr. Pulmonol. 2022, 57, 20–25.
18 Jia Y., Bao, J., Yi M., Zhang Z., Wang J., Wang H., Li Y., Chen O. Impact of the COVID-19 pandemic on asthma control among
children: A qualitative study from caregivers’ perspectives and experiences. BMJ Open 2021, 11, e046525.
19 Castro-Rodriguez J.A., Forno E. Asthma and COVID-19 in children. A systematic review and call for data. Pediatr.
Pulmonol. 2020, 55, 2412–2418.
20 Grandinetti R., Palazzolo E., Rizzo L.; Carbone R., Pisi G., Fainardi V., Esposito S. Impact of SARS-CoV-2 Infection in
Children with Asthma and Impact of COVID-19 Vaccination: Current Evidence and Review of the
Literature. Microorganisms 2023, 11, 1745.
21 Clinical Protocol for Diagnosis and Treatment of Bronchial Asthma in Children. Approved by the Unified Commission on
the Quality of Medical Services of the Ministry of Health of the Republic of Kazakhstan on August 13, 2020, Protocol No. 111.
22 Chuchalin A.G., Avdeev S.N., Aisanov Z.R. et al. Bronchial Asthma: Federal Clinical Recommendations on Diagnosis and
Treatment. Pulmonology. 2022; 32(3): 393–447.
23 Smirnova M.I., Antipushina D.N., Drapkina O.M. Changes in the recommendations for the treatment of bronchial asthma
since 2019. A review of data to assist primary care physicians. Preventive Medicine. 2021; 24(5): 72-80.
24 Porsbjerg C., Melén E., Lehtimäki L., Shaw D. Asthma. Lancet. 2023 Mar 11; 401(10379):858-873. doi: 10.1016/S0140-
6736(22)02125-0. Epub 2023 Jan 19.
25 Koefoed H.J.L., Vonk J.M., Koppelman G.H. Predicting the course of asthma from childhood until early adulthood. Curr.
Opin. Allergy Clin. Immunol. 2022;22:115–122.
26 Khan S., Ouaalaya E.H., Chamberlain J.D., Dufourg M.N., Charles M.A., Semjen C.R. The external validation of the asthma
prediction tool in the French ELFE cohort. Pediatr. Pulmonol. 2022; 57:2696–2706.
27 Xepapadaki et al.World Allergy Organization Journal (2023)16:100727.
28 Wang R., Simpson A., Custovic A., Foden P., Belgrave D., Murray C.S. Individual risk assessment tool for school-age asthma
prediction in UK birth cohort. Clin. Exp. Allergy. 2019; 49:292–298.
29 Kothalawala D.M., Kadalayil L., Weiss V.B.N., Kyyaly M.A., Arshad S.H., Holloway J.W., Rezwan F.I. Prediction models for
childhood asthma: A systematic review. Pediatr. Allergy Immunol. 2020; 31:616–627.
30 Castagnoli R., Brambilla I., Giovannini M., Marseglia G.L., Licari A. New approaches in childhood asthma treatment. Curr
Opin Allergy Clin Immunol. 2023 Aug 1;23(4):319-326.
31 Sumino K., Bacharier L., Taylor J., et al. A pragmatic trial of symptom-based inhaled corticosteroid use in African-American
children with mild asthma. 2020; 8:176.e2–185.e2.
32 Axelsson I., Naumburg E., Prietsch S., Zhang L. Inhaled corticosteroids in children with persistent asthma: effects of
different drugs and delivery devices on growth. Cochrane Database of Systematic Reviews 2019, Issue 6. Art. No.: CD010126.
33 Bacharier L.B., Jackson D.J. Biologics in the treatment of asthma in children and adolescents. Journal of Allergy and
Clinical Immunology 2023; 151:581–589.
34 Paoletti G., Di Bona D., Chu D.K., et al. Allergen immunotherapy: the growing role of observational and randomized trial
‘Real-World Evidence’. Allergy 2021; 76:2663–2672.
35 Tosca M.A., Olcese R., Licari A., et al. Allergen immunotherapy and asthma. Pediatr Allergy Immunol 2020; 31: (Suppl 24):
46–48.
36 Miraglia Del Giudice M., Licari A., Brambilla I., et al. Allergen immunotherapy in pediatric asthma: a pragmatic point of
view. Children (Basel) 2020; 7:58.
